Genomics
1 Transcripts
| WormMine ID | Sequence Name | Length (nt) | Chromosome Location |
|---|---|---|---|
| Transcript:B0213.23 | B0213.23 |
105
 |
V: 3962607-3962711 |
Other
16 Allele
| Public Name |
|---|
| gk963301 |
| gk963591 |
| gk963553 |
| gk964259 |
| gk964351 |
| gk963850 |
| WBVar01587846 |
| gk963027 |
| WBVar02122021 |
| gk964431 |
| WBVar02123284 |
| gk962826 |
| gk962867 |
| gk964442 |
| tm10693 |
| gk231919 |
1 Chromosome Location
|
Feature . Primary Identifier |
Start | End | Strand |
|---|---|---|---|
| WBGene00194990 | 3962607 | 3962711 | 1 |
3 Expression Clusters
| Regulated By Treatment | Description | Algorithm | Primary Identifier |
|---|---|---|---|
| Transcripts that showed significantly increased expression in BAT525 [hmg-3 (tm2539) / dpy-5(e61) unc-13(e1091) I.] comparing to in N2 at 1-day post L4 adult hermaphrodite stage. | DESeq 2, fold change > 4, adjusted p-value < 0.05. | WBPaper00055013:hmg-3(bar24)_upregulated | |
| Transcripts that showed significantly decreased expression in dpy-21(e428) comparing to in N2 during L3 stage. | DESeq v1.6.3. Fold change > 1.5. | WBPaper00050370:dpy-21(e428)_L3_downregulated | |
| Transcripts that showed significantly increased expression after treated by 50uM CGP37157 (7-chloro-5-(2-chlorophenyl)-1,5-dihydro-4,1-benzothiazepin-2-one) for 5 days starting from young adult stage. | DESeq fold change > 2, p-value < 0.05 | WBPaper00061590:CGP37157_upregulated |